Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

China Biologic Produ (CBPO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
China Biologic Announces Corporate Update

Provides Update on New Shandong Facility and Full Year 2017 Financial Forecast --

CBPO : 80.45 (-1.13%)
China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company will...

CBPO : 80.45 (-1.13%)
JPM : 112.27 (-0.36%)
China Biologic Announces Completion of Acquisition of TianXinFu from PWM

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ( "CBPO" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that it has completed the acquisition...

CBPO : 80.45 (-1.13%)
PMTHF : 0.2300 (unch)
China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province

China Biologic Products Holdings, Inc. (NASDAQ: CBPO)("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that, the Company's...

CBPO : 80.45 (-1.13%)
China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province

BEIJING , Dec. 15, 2017 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO )( "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company...

CBPO : 80.45 (-1.13%)
China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited financial...

CBPO : 80.45 (-1.13%)
China Biologic Products to Report Third Quarter of 2017 Financial Results

BEIJING , Oct. 25, 2017 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company...

CBPO : 80.45 (-1.13%)
China Biologic Products to Report Third Quarter of 2017 Financial Results

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans...

CBPO : 80.45 (-1.13%)
China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition

China Biologic Products Holding, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company will...

CBPO : 80.45 (-1.13%)
China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition

BEIJING , Oct. 13, 2017 /PRNewswire/ -- China Biologic Products Holding, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company...

CBPO : 80.45 (-1.13%)
China Biologic Agrees to Acquire TianXinFu from PWM

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("CBPO" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that it has agreed to acquire...

CBPO : 80.45 (-1.13%)
PMTHF : 0.2300 (unch)
China Biologic Receives Approval for Commercial Manufacturing of Human Fibrinogen

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that Shandong Taibang...

CBPO : 80.45 (-1.13%)
Featured Company News - MannKind and One Drop Announce Collaboration to Deliver a Unified Solution for Diabetes Patients

Research Desk Line-up: China Biologic Products Post Earnings Coverage

CBPO : 80.45 (-1.13%)
MNKD : 2.47 (+2.49%)
Investor Network: China Biologic Products, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 3, 2017 / China Biologic Products, Inc. (NASDAQ: CBPO) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 3, 2017 at 7:30...

CBPO : 80.45 (-1.13%)
China Biologic Reports Financial Results for the Second Quarter of 2017

2Q17 Total Sales Up 2.5% YoY and Non-GAAP Adjusted Net Income Up 15.0% YoY in RMB terms, or Total Sales Down 2.3% YoY to $89.3 Million and Net Income Up 0.6% YoY to $31.0 Million in USD terms--

CBPO : 80.45 (-1.13%)
BUYINS.NET: CBPO SqueezeTrigger Price is $103.10. There is $167,164,187 That Short Sellers Still Need To Cover.

BUYINS.NET / www.buyins.net is monitoring China Biologic Products, Inc. (NASDAQ:CBPO) in real time and just received an alert that CBPO is crossing above its primary SqueezeTrigger Price, the price that...

CBPO : 80.45 (-1.13%)
BUYINS.NET: CBPO SqueezeTrigger Price is $103.09. There is $7,164,150,446 That Short Sellers Still Need To Cover.

BUYINS.NET / www.buyins.net is monitoring China Biologic Products, Inc. (NASDAQ:CBPO) in real time and just received an alert that CBPO is crossing above its primary SqueezeTrigger Price, the price that...

CBPO : 80.45 (-1.13%)
China Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders

BEIJING , May 19, 2017 /PRNewswire/ -- China Biologic Products, Inc. ("China Biologic" or the "Company") (NASDAQ: CBPO), a leading fully integrated plasma-based biopharmaceutical company in China...

CBPO : 80.45 (-1.13%)
China Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders

China Biologic Products, Inc. ("China Biologic" or the "Company") (NASDAQ: CBPO), a leading fully integrated plasma-based biopharmaceutical company in China, announced today that the Securities and Exchange...

CBPO : 80.45 (-1.13%)
China Biologic Reports Financial Results for the First Quarter of 2017

1Q17 Total Sales Up 6.9% YoY to $91.5Million and Net Income Up 14.5% YoY to $30.0 Million in USD terms, or Total Sales Up 12.7% YoY and Non-GAAP Adjusted Net Income Up 29.7% YoY in RMB terms--

CBPO : 80.45 (-1.13%)

Van Meerten Stock Picks

My 5 Favorite Mid Cap Stocks
This morning I wanted to find 5 Mid Cap stocks that had great returns over the past year and still seem to have some juice left.
KBH -1.63 , IPGP +2.02 , FSLR -2.19 , NVR -17.23 , SGMS +0.25
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 +0.39%) are up +0.41% at a fresh record nearest-futures high as growth optimism fuels gains in global equity markets. Gains in technology stocks are leading the overall market higher as... Read More

Chart of the Day

Chart of the Day

Audentes Therapeutcs (BOLD) is rhe Barchart Chart of the Day.  The biomedical company has a Trend Spotter buy signal, a Weighted Alpha of 174.58+ and gained 111.74% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures bounced back from Friday’s bearish USDA reports to close Tuesday with gains of 2 cents in most nearby contracts. The weekly Export Inspections report indicated just 584,389 MT of corn was shipped during the week of Jan 11. That is ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.